Pfizer Inc (PFE) 34.64 $PFE
Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
Regarded Solutions - at Seeking Alpha - 1 hr 9 mins ago
JNJ: 99.62 (+1.18), BAX: 70.39 (+0.31), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), HSP: 87.35 (unch), CHRS: 27.11 (-0.71)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Dow 30 Stock Roundup: Cisco, Coke Beat, Microsoft Issues $10.8B in Bonds - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Feb 13, 1:42PM CST
The Dow experienced a mixed week, gaining and losing on alternate days.
KO: 41.99 (-0.18), GS: 189.00 (-0.78), PFE: 34.64 (-0.23), MSFT: 43.87 (+0.78), BA: 149.73 (+1.64), CSCO: 29.43 (-0.03)
Insider Trading Alert - RTEC, PFE And AMRI Traded By Insiders
at The Street - Fri Feb 13, 10:30AM CST
Stocks with insider trader activity include RTEC, PFE and AMRI
PFE: 34.64 (-0.23), RTEC: 12.14 (-0.17), AMRI: 16.94 (-0.28)
FDA accepts Pfizer's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 10:22AM CST
MNK: 115.01 (+2.51), LCI: 57.78 (-0.91), ACT: 285.37 (+3.71), ZGNX: 1.43 (+0.05), PFE: 34.64 (-0.23), ABBV: 58.05 (+1.00), TEVA: 56.77 (-0.58), ALKS: 71.40 (-1.89)
Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)
Business Wire - Fri Feb 13, 9:27AM CST
Pfizer Inc. (NYSE
FE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride), extended-release capsules, an abuse-deterrent formulation (ADF) opioid for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ALO-02 is an extended-release oxycodone specifically designed to reduce abuse via the oral, intranasal (i.e., snorting) and intravenous (IV) routes when crushed.
PFE: 34.64 (-0.23)
Prader Willi Syndrome Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com
PRWeb - Fri Feb 13, 8:31AM CST
The report "Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS). Prader-Willi syndrome is a complex genetic condition. It is a rare disorder present at birth that results in a number of bodily, psychological and behavioral problems. Prader-Willi Syndrome occurs in approximately one out of every 15,000 births. Prader-Willi syndrome is caused by the thrashing of genes in a precise area of chromosome 15. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available @ http://www.rnrmarketresearch.com/prader-willi...eport.html .
PFE: 34.64 (-0.23)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST
PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Biosimilar firms up on Remicade patent rejection
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:56AM CST
JNJ: 99.62 (+1.18), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), EPRS: 7.67 (+0.67), PFNX: 12.45 (+0.29), HSP: 87.35 (unch), NVS: 102.20 (-0.17), CHRS: 27.11 (-0.71)
Next Resistance Level for Pfizer (PFE) is $34.76
Comtex SmarTrend(R) - Thu Feb 12, 11:38AM CST
Pfizer (NYSE FE) has opened bullishly above the pivot of $34.25 today and has reached the first level of resistance at $34.51. Should the shares continue to rise, the resistance pivots of $34.76 and $35.27 will be of interest.
PFE: 34.64 (-0.23)
Hospira Beats on Q4 Earnings, Set to Be Acquired by Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 9:28AM CST
Hospira's fourth-quarter 2014 adjusted earnings of 53 cents per share easily beat the Zacks Consensus Estimate of 41 cents.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), PFE: 34.64 (-0.23), HSP: 87.35 (unch)
2015 New-Year Coverage Universe Updates
DAG Investments - at Seeking Alpha - Thu Feb 12, 9:10AM CST
ACET: 20.00 (+0.27), GE: 25.15 (+0.26), KR: 72.86 (+0.41), BX: 37.40 (+0.49), CCLP: 16.61 (+0.44), CECE: 14.70 (+0.23), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), SPWR: 28.30 (+0.07), HLS: 45.01 (+0.30), MTW: 21.86 (+0.34), AET: 96.12 (-0.96), MWA: 9.19 (+0.09), VLO: 58.60 (+2.05), FSLR: 48.84 (-0.58), WBA: 78.73 (-1.23), RJF: 57.05 (-0.36), TRN: 29.79 (+0.33), CWCO: 10.62 (-0.02), WMB: 49.41 (+1.44), ANAC: 40.76 (-0.07), SXI: 71.53 (-0.23), IHG: 40.34 (-1.03)
'Fast Money' Recap: Tesla a Rough Ride, Whole Foods Half Baked
at The Street - Thu Feb 12, 4:00AM CST
The trading panel discussed Tesla's latest quarterly results and the challenges the stock faces Thursday. Whole Foods got a mixed review, as well.
WFM: 56.15 (-0.15), KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), FEYE: 42.26 (+2.63), LGF: 32.17 (+0.08), PFE: 34.64 (-0.23), PANW: 135.27 (+2.26), CSCO: 29.43 (-0.03)
Market Maker Surveillance Report. PFE, SIRI, AAPL, BLDP, EWJ, RSX, Highest Net Buy Volume With Lowest Price Friction For Wednesday, February 11th 2015
M2 - Thu Feb 12, 1:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5280 companies with "abnormal" market making, 2471 companies with positive Friction Factors and 3635 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Wednesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Pfizer Inc (NYSE FE), Sirius XM Radio Inc (NASDAQ:SIRI), Apple Inc (NASDAQ:AAPL), BALLARD POWER SYSTEMS INC (NASDAQ:BLDP), Ishares Msci Japan Index Fund (NYSE:EWJ), Market Vectors Russia ETF (NYSE:RSX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
BLDP: 2.66 (-0.26), PFE: 34.64 (-0.23), RSX: 18.05 (+0.39), AAPL: 127.08 (+0.62), SIRI: 3.83 (-0.07), EWJ: 11.93 (+0.14)
38.69% Edge To 5 Dow, Highest Yield, Lowest Price, February Stocks With Merck
Fredrik Arnold - at Seeking Alpha - Wed Feb 11, 11:48PM CST
T: 34.66 (+0.05), GE: 25.15 (+0.26), PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), XOM: 93.37 (+1.00), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21)
Elite 10 Dow Dividend Dogs Display 9.72% To 18% Upsides For February
Fredrik Arnold - at Seeking Alpha - Wed Feb 11, 8:40PM CST
GE: 25.15 (+0.26), AXP: 78.08 (-2.40), NKE: 92.04 (+0.04), UNH: 109.44 (-0.40), PFE: 34.64 (-0.23), INTC: 34.36 (+0.23), T: 34.66 (+0.05), JNJ: 99.62 (+1.18), JPM: 59.67 (+0.10), MRK: 58.81 (-0.07), DD: 76.18 (-0.11), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), MSFT: 43.87 (+0.78), VZ: 49.31 (-0.21), CSCO: 29.43 (-0.03)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
The Dogs Of The Dow Get Off To A Sluggish Start In 2015
Value Line - Seeking Alpha - Wed Feb 11, 6:30PM CST
By Robert M. Greene The year got off to a slow start for The Dogs of the Dow, as these stocks had limited success overcoming the headwinds in the broader equity markets. In all, an equally-weighted position in the 10-highest yielding Dow stocks at...
PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92)
Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
Regarded Solutions - at Seeking Alpha - 1 hr 9 mins ago
JNJ: 99.62 (+1.18), BAX: 70.39 (+0.31), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), HSP: 87.35 (unch), CHRS: 27.11 (-0.71)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Dow 30 Stock Roundup: Cisco, Coke Beat, Microsoft Issues $10.8B in Bonds - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Feb 13, 1:42PM CST
The Dow experienced a mixed week, gaining and losing on alternate days.
KO: 41.99 (-0.18), GS: 189.00 (-0.78), PFE: 34.64 (-0.23), MSFT: 43.87 (+0.78), BA: 149.73 (+1.64), CSCO: 29.43 (-0.03)
Insider Trading Alert - RTEC, PFE And AMRI Traded By Insiders
at The Street - Fri Feb 13, 10:30AM CST
Stocks with insider trader activity include RTEC, PFE and AMRI
PFE: 34.64 (-0.23), RTEC: 12.14 (-0.17), AMRI: 16.94 (-0.28)
FDA accepts Pfizer's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 10:22AM CST
MNK: 115.01 (+2.51), LCI: 57.78 (-0.91), ACT: 285.37 (+3.71), ZGNX: 1.43 (+0.05), PFE: 34.64 (-0.23), ABBV: 58.05 (+1.00), TEVA: 56.77 (-0.58), ALKS: 71.40 (-1.89)
Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)
Business Wire - Fri Feb 13, 9:27AM CST
Pfizer Inc. (NYSE
FE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride), extended-release capsules, an abuse-deterrent formulation (ADF) opioid for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ALO-02 is an extended-release oxycodone specifically designed to reduce abuse via the oral, intranasal (i.e., snorting) and intravenous (IV) routes when crushed. PFE: 34.64 (-0.23)
Prader Willi Syndrome Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com
PRWeb - Fri Feb 13, 8:31AM CST
The report "Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS). Prader-Willi syndrome is a complex genetic condition. It is a rare disorder present at birth that results in a number of bodily, psychological and behavioral problems. Prader-Willi Syndrome occurs in approximately one out of every 15,000 births. Prader-Willi syndrome is caused by the thrashing of genes in a precise area of chromosome 15. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available @ http://www.rnrmarketresearch.com/prader-willi...eport.html .
PFE: 34.64 (-0.23)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST
PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Biosimilar firms up on Remicade patent rejection
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:56AM CST
JNJ: 99.62 (+1.18), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), EPRS: 7.67 (+0.67), PFNX: 12.45 (+0.29), HSP: 87.35 (unch), NVS: 102.20 (-0.17), CHRS: 27.11 (-0.71)
Next Resistance Level for Pfizer (PFE) is $34.76
Comtex SmarTrend(R) - Thu Feb 12, 11:38AM CST
Pfizer (NYSE
FE) has opened bullishly above the pivot of $34.25 today and has reached the first level of resistance at $34.51. Should the shares continue to rise, the resistance pivots of $34.76 and $35.27 will be of interest. PFE: 34.64 (-0.23)
Hospira Beats on Q4 Earnings, Set to Be Acquired by Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 9:28AM CST
Hospira's fourth-quarter 2014 adjusted earnings of 53 cents per share easily beat the Zacks Consensus Estimate of 41 cents.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), PFE: 34.64 (-0.23), HSP: 87.35 (unch)
2015 New-Year Coverage Universe Updates
DAG Investments - at Seeking Alpha - Thu Feb 12, 9:10AM CST
ACET: 20.00 (+0.27), GE: 25.15 (+0.26), KR: 72.86 (+0.41), BX: 37.40 (+0.49), CCLP: 16.61 (+0.44), CECE: 14.70 (+0.23), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), SPWR: 28.30 (+0.07), HLS: 45.01 (+0.30), MTW: 21.86 (+0.34), AET: 96.12 (-0.96), MWA: 9.19 (+0.09), VLO: 58.60 (+2.05), FSLR: 48.84 (-0.58), WBA: 78.73 (-1.23), RJF: 57.05 (-0.36), TRN: 29.79 (+0.33), CWCO: 10.62 (-0.02), WMB: 49.41 (+1.44), ANAC: 40.76 (-0.07), SXI: 71.53 (-0.23), IHG: 40.34 (-1.03)
'Fast Money' Recap: Tesla a Rough Ride, Whole Foods Half Baked
at The Street - Thu Feb 12, 4:00AM CST
The trading panel discussed Tesla's latest quarterly results and the challenges the stock faces Thursday. Whole Foods got a mixed review, as well.
WFM: 56.15 (-0.15), KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), FEYE: 42.26 (+2.63), LGF: 32.17 (+0.08), PFE: 34.64 (-0.23), PANW: 135.27 (+2.26), CSCO: 29.43 (-0.03)
Market Maker Surveillance Report. PFE, SIRI, AAPL, BLDP, EWJ, RSX, Highest Net Buy Volume With Lowest Price Friction For Wednesday, February 11th 2015
M2 - Thu Feb 12, 1:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5280 companies with "abnormal" market making, 2471 companies with positive Friction Factors and 3635 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Wednesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Pfizer Inc (NYSE
FE), Sirius XM Radio Inc (NASDAQ:SIRI), Apple Inc (NASDAQ:AAPL), BALLARD POWER SYSTEMS INC (NASDAQ:BLDP), Ishares Msci Japan Index Fund (NYSE:EWJ), Market Vectors Russia ETF (NYSE:RSX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . BLDP: 2.66 (-0.26), PFE: 34.64 (-0.23), RSX: 18.05 (+0.39), AAPL: 127.08 (+0.62), SIRI: 3.83 (-0.07), EWJ: 11.93 (+0.14)
38.69% Edge To 5 Dow, Highest Yield, Lowest Price, February Stocks With Merck
Fredrik Arnold - at Seeking Alpha - Wed Feb 11, 11:48PM CST
T: 34.66 (+0.05), GE: 25.15 (+0.26), PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), XOM: 93.37 (+1.00), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), VZ: 49.31 (-0.21)
Elite 10 Dow Dividend Dogs Display 9.72% To 18% Upsides For February
Fredrik Arnold - at Seeking Alpha - Wed Feb 11, 8:40PM CST
GE: 25.15 (+0.26), AXP: 78.08 (-2.40), NKE: 92.04 (+0.04), UNH: 109.44 (-0.40), PFE: 34.64 (-0.23), INTC: 34.36 (+0.23), T: 34.66 (+0.05), JNJ: 99.62 (+1.18), JPM: 59.67 (+0.10), MRK: 58.81 (-0.07), DD: 76.18 (-0.11), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), MSFT: 43.87 (+0.78), VZ: 49.31 (-0.21), CSCO: 29.43 (-0.03)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
The Dogs Of The Dow Get Off To A Sluggish Start In 2015
Value Line - Seeking Alpha - Wed Feb 11, 6:30PM CST
By Robert M. Greene The year got off to a slow start for The Dogs of the Dow, as these stocks had limited success overcoming the headwinds in the broader equity markets. In all, an equally-weighted position in the 10-highest yielding Dow stocks at...
PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92)
